Optometrist

Episode 85 - Mr. Alfonso Cerullo, President Of LensCrafters - The Future Of Canadian Optometry

TTTP 85 Alfonso | LensCrafters

Given the challenges in our country, like COVID, and the current state of Canadian optometry, Canada still has a solid market from a business perspective. As a profession, Canadian optometry still has a high demand for doctors to grow because of the elements which play a massive role in the industry. In the fifth installment of The Future of Canadian Optometry Series presented by Aequus Pharma, Dr. Sian speaks with Mr. Alfonso Cerullo about his perspectives on the profession's future. Mr. Cerullo shares his thoughts on the following topics: independent vs. corporate optometry, what increasing access to care means, the value of the eye exam, and emerging technology. Tune in to this episode and be sure to check out the entire series of interviews with leaders from various large organizations in the Canadian optometry space.

Watch the episode here

Listen to the podcast here

Mr. Alfonso Cerullo, President Of LensCrafters - The Future Of Canadian Optometry

This is the fifth of six installments or the fifth of six interviews that I'm doing with leaders from various organizations across Canada that have footprints within the Canadian optometric market and in the industry. Generally speaking, they are large players in the industry. We are talking FYIdoctors, Specsavers, IRIS, and LensCrafters, which is going to be our interview.

If you haven't heard the previous four interviews, I highly encourage you go check out Dr. Alan Ulsifer from FYIdoctors, Dr. Daryan Angle from IRIS, and Mr. Bill Moir from Specsavers. All of these interviews have been valuable and truly insightful into what the future of Canadian optometry is going to look like from the perspective of these different leaders in different organizations.

What I have said along the way is that some of these guests have been very candid and very open. They have been open to discussion, open to face these questions head-on, and open to answering the question that I'm asking. Some guests are not so open. It has been interesting to hear your feedback as these episodes have been rolling out and to hear feedback from people who are listening and from my colleagues who tell me, “This person was open. This person was not so open.”

I appreciate that feedback. I appreciate you sharing. As I always make the request, please do share this with our colleagues across the country, whether you post it on Instagram, or post a link on LinkedIn or Facebook. Send a text with the link to your friends so they can tune in, whether they are watching on Facebook, YouTube, Spotify, Apple, Stitcher, or wherever platform because all of these conversations are valuable.

What I would love for everyone to take away from this is that we all need to be collaboratively, as optometrist and as colleagues, pushing in the right direction. Pulling in the right direction or however you want to look at it, and making sure that the public has the highest possible perception of our profession and what we do in the service we provide.

The fifth of the six episodes is with Mr. Alfonso Cerullo who is the President of LensCrafters and For Eyes. LensCrafters is one of the biggest retail met brands in North America and the biggest one under the EssilorLuxottica banner. Having Mr. Alfonso Cerullo on was very interesting and sharing some valuable insights. One, I'm going to tell you right off the top. I love that Alfonso shared that optometrists have the power. We have the power to decide which direction our profession is going, and which corporation we want to work with, whether we want to work independently. Ultimately, we have the power

 If we make a decision to work with a certain organization that may not be driving the profession in the right direction, that's on us. If we make the decision to work in a certain direction to make sure the perception of our profession is always elevated, that's on us. That's our responsibility. Without giving away too much from this interview, here is the conversation with Mr. Alfonso Cerullo. I hope you enjoy it.

Mr. Alfonso Cerullo, thank you so much for taking the time to join me here on the show, in particular for this very special set of conversations that we are having that I have called The Future of Canadian Optometry. Thank you very much for joining me here.

Thank you, Dr. Harbir, for the opportunity. Thank you so much.

My pleasure. Alfonso, you probably know this now. A few months back, I put an invitation on the show to invite leaders like yourself and from other organizations to come on to share their thoughts about what's going on in our profession right now. I ask every guest at the beginning of each interview that I would love it if you could be as candid and open as possible to share your thoughts on what you think is going on these days. I start every guest with the same question. From your perspective as president of LensCrafters and For Eyes, what do you think is the current state of optometry in Canada now?

I have to say that from a business perspective, Canada is a very strong market for us. Looking back to the last months, this 2022, then also starting from the middle of 2021, we are doing very well. It's a very solid and strong market. We are very happy to be there. We are also experiencing some trends that start a little bit early here in North America. Many related to the doctor and supply. There is a strong need for doctors, and if we don't handle this carefully, it could be a potential challenge for the Canadian market.

TTTP 85 Alfonso | LensCrafters

LensCrafters: There is a strong need for doctors, and potentially if we don't handle this carefully, it could be a potential challenge for the Canadian market.

For optometry as a profession, from what you've seen in Canada, particularly, and from the service provider's or optometrist's perspective, do you think that the profession is strong? Is it growing or is it doing well? Do you see some pitfalls or challenges right now?

There are several types of challenges. We cannot forget COVID. COVID-19 starting in 2020 has been a strong element of disruption for all of us and any professional in this market. Including the ODs. All of us out there are trying to rethink how to do the things that we used to do in a different way. Technology played a strong role during COVID. As a result, people change their mindset personally and also the ODs. The work-life balance became even more a very important element in the life of people and the life of doctors.

This generates some change in some disruption in the industry. On top of those that I just mentioned, let me say there’s a lack of supply. We need more doctors. We know that there are more practices that are growing. There are new players coming into the market. The demand for doctors is going to grow. Let me say together with these different needs that the people have over work-life balance, this can generate some disruption. As I said before, technology can come in our favor like tele-optometry and remote care. This could be an element that can mitigate these potential needs.

That's something we are going to touch on in a little bit. You use the term disruption there a couple of times. That is going to be my next question. It is related to disruption and the various disruptive forces. COVID was maybe the biggest global disruptive force that we have faced together. Here in Canada, what other forces would you say are potentially disruptive? We hear a lot about consolidation, new players, and eCommerce. Which of those do you feel is maybe playing a bigger role? What do you think optometrists should be looking for?

All of the things that you mentioned are already there. All of the things that we know in the market. There are new players that are coming out there that have their own strategies. eCommerce is playing a big role. Considering how important is eye care or vision care, one of the most important elements that we should look at very carefully is the availability of doctors or the number of doctors that we have in the market. LensCrafters operates in US and Canada, but looking overall at North America, we know that on average, there are 1,700 new grads joining the community. It’s a little bit less or a little bit more every year. They are joining the family.

When you look at the number of doctors every year who retire, they are almost in the same range. You have 1,600 or 1,700. In terms of head counts, and the number of people or doctors that are available to serve the community, we are almost there, but then there is a material element in terms of work-life balance that is reducing the availability and the access to the care to the entire market and community. Together with the fact that there are more doors. Yes, there are new players coming, but there are also private entities in corporate businesses that want to open new practices in the market.

On one hand, this is something very good for us because it means that this industry is very healthy. There are new operators that want to come. What is important is to make sure that we are continually giving access to care, which is the final goal of all of us. We are continuously giving high-quality vision care to patients.

What is important is to ensure that we are continually giving access to care and high-quality vision care to the final patient.

We need to make sure that we make it appealing to new people or young potential doctors in this profession, the doctors and the ODs. We need to work with schools and make sure that the school of optometry are very visible and there are more doctors that are joining them. We are supporting ASCO in all ways possible. One of their last campaigns is Optometry Gives Me Life.

We have been a leading supporter of this campaign to make sure that new generations see optometry as a very solid and strong profession from a business and professional standpoint. They can be very instrumental in serving the community, for access to care, and giving the gift of sight to the people. I strongly believe that as long as we have enough doctors and the doctor community is strong out there, all the other elements that can be disruptive are mitigated. That's what I think.

There has been a lot of talk about this during the series of conversations that I have had. There’s a fair amount of talk about the demand or the potential lack of supply of optometrists. You touched on a couple of things that make the profession seem desirable and attractive to potential candidates and students who may be going into that path. That's one of the questions I will probably be asking you again towards the end of the interview. Do you feel that having more schools is part of the answer?

I don't know if it is a matter of the capacity of schools and if we need more schools. There are some states at least in the US where there are areas that are not covered by schools. This can facilitate access to the schools and make sure that the people choose to go and choose an optometry school that they want to go to. What we need to do even more than most schools is to create a strong awareness of this profession. Making sure that when the students out of high school have to decide, they know that there is a strong profession out there that the market needs. There is a stronger demand. It’s a good moment to join this industry.

These are the things that we need to make sure from everywhere, and that these new potential doctors are knowledgeable and they know. They have this awareness that the doctor, the ODs, and the optometrist are out there. It’s something that can be good for them. I guess that now, optometry doesn't have the same level of awareness of the people that should choose a school that another type of profession has.

As part of that conversation of there being not enough doctors, some have suggested through these conversations that there should be more schools. There should be more acceptance of students, and therefore greater output of ODs on the other side of it. I will say within the OD community, there's some concern that if that's the case, then it lowers the bar to entry and therefore lowers potentially the quality of the professional that's being out there and being put out there. It then devalues almost the profession in a way, if there's now potentially an oversupply of ODs at some point. Do you feel that that's a legitimate concern? Is that something that may happen?

I have had several opportunities to talk with the schools. The schools of optometry will never allow that. They will never ever lower the bar down to let more people get in. It's something that I don't think is going to happen. All the schools that I had the opportunity to speak to always made this point. It's more a matter of having more people trying to start this school, trying to start this profession, and trying to become optometrists, rather than saying, "Considering that we don't have much, let's lower the bar down.” I don't think that this is something that is going to happen. It’s a risk. I don't think it's happening, and I hope that it is not going to happen.

The schools of OME will never allow lowering the bar down to let more people get in.

The core question that I post when I put that initial invitation to the various organizations in our industry was, what is your organization doing to support the profession of optometry as a whole to help the profession in Canada to grow and thrive in the future? I would like to know from your perspective and as president of LensCrafters or if you are willing to speak beyond that to EssilorLuxottica as a whole, what would you say is the organization doing to support optometry?

A quick introduction. We know that LensCrafters is part of the EssilorLuxottica group. EssilorLuxottica is a new company that is coming from the integration of Essilor and Luxottica. It's the bigger player on a global scale in this industry, and LensCrafters is the optical retail chain here in North America. It’s the corporate retail chain.

We are part of a vertically integrated business. All we do is all about spectacle and eye care instruments. We round the industry. We’re trying to be an open player to elevate the industry. Even because of the position that we have as the leader of the industry, we strive to let this industry grow. Only if the industry grows that we can grow in terms of business.

Looking at LensCrafters, it's our biggest optical retail chain in North America. We have overall 1,000 stores split between the United States, Canada and Puerto Rico. All we do is make sure that we provide high-quality eye care and eyewear. That's what we do. If you look at our brand value proposition, we want to set the standard in the industry to make sure that every patient every day in every store can have these high-quality eye care and eyewear.

Also, we always say, and this is something public that we are always sharing in the market, we want to be the trusted optical retailer in the community. Trust is something very important for us. You build trust. Thanks to the many things that you have to do as an optical retailer. Good stores, equipment, product and environment, but mainly good doctors. When you look at the community and you want to be a trusted optical retailer, the doctor is essentially one of the main characters of what we are doing.

TTTP 85 Alfonso | LensCrafters

LensCrafters: So when you look at the community and want to be a trusted optical retailer, the doctor is essentially one of our main characters.

We work around you to make sure that the doctor is very visible in the community. He can showcase the high-quality service that we can provide. The question is, what do we do? First of all, we are always committed to making sure that we are always a cutting-edge store. Our remodeling and relocation of new stores is something that is part of our strategy. It’s a constant element. We are talking huge investment in terms of CapEx, and this is one of the elements. The doctors that want to join us can see that they are joining a company that is looking at the store as a key element of the community, and put them in a position to showcase a high-quality journey. That’s the first one.

The second one. When a doctor joins us, in both cases, if it is an employee where it is allowed by law or if it's a sublease, a doctor that is joining but is a completely independent doctor, at which we are subleasing part of our stores. In both cases, we make sure that we always have up-to-date equipment for this doctor. We make sure that all the best technology that is out there in the market is present in this practice at a very convenient price.

This equipment can be very expensive. You can have an optomap. You can have the Drum, this digital refraction equipment and all this stuff. Setting up the practice can be a challenge mainly for new graduates because they are also paying for their schools. By joining LensCrafters, they can have all this technology in a very beautiful store with a very good deposition in the community, and at a very affordable price. Everything is included in the lease.

It's important to say that you will never feel alone in LensCrafters because this doctor is going to join a huge community. We are more than 800 sublease doctors and more than 2,300 employees. The community is very big. When I say 800, it is the sublease holder. In each practice or the sublease holder, there are other doctors. You can multiply the 800 by 2. We are talking about thousands of doctors that are part of this community. They will receive newsletters. We have a moment that we come along together and so on and so forth.

Also, we are a leading player in all the major industry events. Many of them are in the United States, but I also know that the majority of doctors that I know from Canada used to join it when they were talking about AOA, the Academy, Vision Expos, and East and West. Everyone is coming there to understand where the industry is going. In all of these, there's always a leading player. It's a solid company that invests money to make sure that we are providing high-quality eye care. You can join a huge community of doctors, so you can be up to date and be part of it, and you can have a leading position in all major industry event

In the terms of making sure the profession continues to grow. You've described there a setting for an optometrist to grow and pursue their career, and be part of a community. It's nice from that individual optometrist's perspective. We are looking across the entire country, for example, with various challenges that are happening such as in Ontario with their negotiations with the government there and things like that. How would you say LensCrafters is elevating the profession or strengthening the profession of optometry in those types of situations?

The example that I always used to share is the following. Now, if you want to be an independent doctor and you are a new grad, it is not going to be easy. You have a lease. You need to build the practice so you have CapEx investments. You need to keep your practice up to date, always beautiful, and showcase who you are. You need to maintain this practice. You need to have personnel and people working for you. It depends if you just want to be a doctor at just an eye care practice, or you’re also selling spectacle products out there. That situation is even more complicated. You need to manage a back office. It's not just about people, but you need to have also technology and instruments to manage the back office.

You need to have a website. You need to invest in marketing to be visible in the community. You need to have an HR and a system to let you manage the practice. You need to have an appointment booking management tool to make sure that you can handle your booking in a good way or in a seamless way. All these things are all challenges that when you are a doctor managing your practice by yourself can be a headache instead of joining a big optical retailer or a big organization like LensCrafters where you can have a lot of these things with a very affordable sublease contract.

You are already joining a company that has a strong guide within the community. You have a company that is already giving you a practice that is remodeled and fresh with equipment and everything. You already have a system and back office. Now, if you have any kind of equipment or instruments that is not working, it’s independent. It’s on the practice to make sure that this is working.

We have all back office, contact centers, and eye care operation teams that are making sure our doctor community can be always up and running in a good way. Nobody is perfect. You can have areas for improvement, but in terms of the operative model, we always try to serve our doctors in the best way possible, and the service level is pretty good.

TTTP 85 Alfonso | LensCrafters

LensCrafters: You can always have areas for improvement, but in terms of the operative model, we always try to serve our doctor to come in the best way possible.

You touched on the word corporate or corporation. That is the next question I was going to ask you. From when I was in school, and I know it’s from higher years as well, but the conversation starts to happen while you are in optometry school. It’s this division between independent and corporate optometry. I would like to hear your thoughts on what you think and if you could define each of those, and then where does the LensCrafters model fall in that?

What I’m going to say is pretty straightforward. It could be strong. This definition is one of the most confusing definitions in the industry. When I joined this industry, I'm a managerial engineer. I'm an engineer and I spend most of my life in consulting. During my professional life, I joined Luxottica, and then I start looking after this optical retail business, first in Australia and then here.

At a later age, I got in contact with this definition, and it's confusing because you have corporate and independent. Normally, what we mean by this is corporate are all the big operators of the optical retail chain. That's the overall definition that the majority of the people land on. We have the independent that is the single doctor with his own practice and so on and so forth.

It's a way to define something. If this is the definition, it's pretty clear. Where I focus on is what we want to mean with the corporate retail chain and independent. If all of us have the interest to define what type of eye care service we are providing to the community, so then it is worth understanding and clarifying.

For me, the important thing in any definition that we use is to make sure that the doctor is independent in the sense that he can manage and execute his profession in the best way possible without any condition. That's the way because you need to provide an eye care service to the community, and this should not be influenced by anything else. You should be independent.

Make sure the doctor is independent because he can manage and execute the profession in the best way possible without any conditions.

If instead you are employed in an organization, you should make sure that you are this independent. You are executing your job in a way that you are still providing this service to the community. In LensCrafters, to keep our life easy, we have both of them. The majority, more than 800 stores have this sublease model. What does this mean? For me, it’s one of the best ones because you have an independent sublease doctor that is operating in his own practice as an independent. He is not influenced at all by any sales coming from the product and material because he's not sharing any profit from the product and material. He's just operating next to LensCrafters.

It’s all the things that I told you before. He made his own decision and say, “I want to join LensCrafters. It's a strong brand. I can have traffic over there. They invest in marketing for me. They give me all these eyecare operation tools that I can operate in my practice. It's good to go there,” but he's independent. He’s got nothing to do with us. This is the model that we have in Canada.

In the United States, we have the majority of subleases but we have also employed doctors. When it comes to employed doctors in the United States, we strive for continuous employment, with continuous learning, with the processes and procedures to make sure that whatever is happening on the other side of the business, the doctor follows on the eye care. There is no difference in terms of equipment. The equipment is the same.

There is no difference in terms of the time that we dedicate to the patient in employed stores or in sublease stores. All the metrics and KPIs, when you look at it, are very much comparable. We are obsessed to make sure that these KPIs on both channels are very aligned because what we want is to provide high-quality eye care. Personally, the sublease model can remove any doubt because you are providing the best eye care backed by strong operators that can provide the best eyewear.

TTTP 85 Alfonso | LensCrafters

LensCrafters: The LES model can remove any doubt because you are just providing the best eyecare begged by a strong operator. So that can provide the best.

The definition is implying something, especially the way that it was always presented to us in school, and the implication is that corporate optometry is the less desirable route. The evil corporations will set you up that way, and the understanding or implication is that they are determining how you practice. They are determining how many patients you see. I know in some organizations, from what I understand anyways, that is the case. How many patients do you see? How much time do you spend on each patient? I would like to know your thoughts on that. Is that something that is generally the LensCrafters' perception of that?

I have to be very honest. I spoke with our independent doctors and then we look at our business as LensCrafters. There are two answers to your question. The first one is the availability of the doctor and the access to care. If you ask me, considering how important is access to the care, everybody, independent, corporate, hybrid model like LensCrafters, we have sublease and we’re corporate. Everybody should strive to increase access to care. If there is someone in the community that need an exam, he should be in the position and in the condition to have an exam.

Seven days, that's the goal where I try to strive to give access to care to the community as much as possible. Every day over the week. How we can achieve this is a little bit different because if you want to provide high-quality eye care, you cannot have a doctor seven days a week, ten hours a day. That's unfair. That's not good. This doctor is tired. He is not in the best position to provide a high-quality service. You need to organize your practice in a way that you can maximize access to care and make sure that you can guarantee your people a good work-life balance to keep them fresh and relaxed to provide the best service. One is access to care.

TTTP 85 Alfonso | LensCrafters

LensCrafters: Organize your practice in a way that you can maximize access to care and make sure that you can guarantee your people a good work-life balance and keep them fresh and relaxed to provide the best service.

The other one is productivity and the way you want to execute your practice. I think that we are pretty much aligned. There are practices that used to see 10 to 12 people on peak days, and there are practices that on average used to see from 5 to 8. At the end of the day, if you have a doctor in the room managing twelve exams throughout the day is a fair amount of exams to provide a good quality eye exam, and also manage the productivity to keep financial stability for independent practice. Between 12 and 15 is something that is very fair to manage.

You mentioned that you had spent some time in Australia.

I have been there from 2017 until 2020.

The big elephant in the room these days in Canada is Specsavers, and the splash they have made in the last several months or whatever it is since they have made their entrance here in BC. It wasn't directly because of Specsavers, but a lot of the impetus for this conversation and these conversations that we are having is due to the second order, third order effects that have happened.

Other somewhat organizations are recruiting harder ODs and staff, poaching ODs from other places, and things that are happening in response to these waves that are being made. A lot of ODs, all of us essentially, across the country are a little bit on edge like, what is this going to mean for the profession? What is it going to look like 10 years from now?

We try to look to other markets where changes like this have happened and where Specsavers has come in. They originated in the UK, but Australia was the market where we know that they made a big impression if we want to use a diplomatic word. I would like to hear your thoughts as much as you are comfortable sharing. From your time in Australia, wow do you know or what do you understand of the market changing in the period of time after Specsavers entered?

In Australia, I was looking after the OPSM chain. In Australia you have OPSM and you have two historical optical retail chains in this market. When Specsavers came into the market, I was not there. I came later on. What I have been told is that they made the promise to the market, “We’ll open 100 stores in 100 days." This was the call to action that they open in this campaign and this journey in Australia, and they made it.

They did a great job. They went there and they opened a practice. They respected exactly the timeline of what they did. About how they operate, I cannot comment. I cannot say anything. Everybody out there is trying to do their best or what they can. Any kind of effect that you may have from the coming of an operator like Specsavers into the market, this effect is completely in the hand of the doctor. The doctors have 100% the power to make this phenomenon a big disruption or nothing. Specsavers, like all of us, need doctors. The only way that they can be successful is if the doctor is going that way.

It's a little bit interesting the dynamic because you see doctors that are very scared about this. I don’t know if they would be successful like Australia, but in case they will be, that scenario would be exactly the doctor that will allow this. Isn’t it interesting, this stuff? The only thing that I can say is that the doctor has the power. They should understand exactly what they are going to do, and then make their choice. You cannot eat the cake and have it.

That's a fair point. The optometrists are demanding. We want the cake and we want to eat it too. That's the way we work. We have talked about the importance of the eye exam. One of the questions that I'm asking everybody is how do we create the perception of value through the eye exam service? How do we leave a patient feeling that the eye exam was worth the amount of money that they paid, hopefully, beyond or exceeding the amount of money that they paid? In your opinion, what have you seen on that side of the business in the eye exam? From the eye doctor's perspective, how do we create that value?

There are two key elements on this point. The first one, which is your first point, is perception. This is based on the awareness that the people have about the site and about eye care. In a world where the industry becomes a commodity, there are many operators that go in that direction. It's about price. It was about cheap. It's about the spectacle on the face of people because, with the price that they have, they cannot afford all the extra costs to provide high-quality eye care. The more we go into a world where the industry becomes a commodity, the more the customers don't see the worth of an eye exam.

TTTP 85 Alfonso | LensCrafters

LensCrafters: The more we go in a world where the industry becomes a commodity, the more we play and communicate as much as possible in the industry as a word of mind instead.

Instead, the more we play together and communicate as much as possible in the industry through word of mouth when a customer or a patient is in the doctor's room, or any magazine of the industry. How important is it to take care of your eyes? How much can you discover about your health testing and have an eye test? I don't remember, but it’s probably something like 80 or 90 different types of disease. You are a doctor, you know better than me, but how many can be discovered by just inspecting the eye? You can save lives by having an eye exam.

The more we are able to let the patient in their interest know that they should have annual exams. They know that it's important to have an annual exam for their safety and for their health, and they take care of their eyes like they take care of their teeth. You go to the dentist probably every month, every eight weeks, or every three months. There are many people that don't visit an optometrist every year. This is something that all of us need.

If we do a good job in letting everybody understand how important it is to do annual eye exams and how important it is to inspect your eye, not only for the good side, it is the main things, but for many other things, the more the customer has the attitude to approach the eye exams and strive and look for a high-quality exam. He’s also willing, if he has to pay, to pay more because he understands the value.

I have been in practice where the customer has been moving across pre-test and test, across 6, 7 and 8 different equipment without telling him anything. He doesn't see any value. We spend time in LensCrafters explaining what an optimal piece is. What are we doing with the vision fee? What does this mean when I'm doing the refraction? We spend time after the eye test. The doctor spends time with the patient to make him understand, “That's the overall situation. That's where you are.” Let him understand the situation regarding his health and his eye. The more we do that, the more he is willing to pay and so on and so forth.

The second question is the feeling. Do I feel good enough? Is it worth the money that I spent? Honestly, back to the first point. When you have a good expectation, then you can evaluate if this expectation is fulfilled, and then you can make a choice. It’s not only based on the price, “It’s a very good deal. I didn't pay anything.” You can make a choice on price and on service. You create the feeling later on. If you are in a world where everybody understands the importance to take care of their eye, so then people are willing and open to pay if you are a good operator in the community and you are providing a high-quality service. The competition then is on the service rather than on the price.

If everybody understands the importance of taking care of their eye, then people will pay. And if you are a good operator in the community, you are providing a quality service, then the competition will be on the service rather than the price.

Many of us understand or appreciate the fact that if it's a race to the bottom and if it's a matter of commoditizing and lowering the price, it's ultimately going to devalue the service or the perception of the service. On the flip side, I'm curious to hear what you think about if you do have a patient in front of you who values the service that they are getting. They understand that we can potentially find these multitudes of diseases.

The service provider or the clinic provides a very high-quality eye exam with all of the things that you mentioned like the technology and education aspect. On the low-end, you could go all the way down to $0 and give an eye exam for free, but on the high-end or the other end, it doesn't have to be at the very high-end. How much do you think a provider with that high-quality comprehensive eye exam should be charging?

Canada is a little bit different from the US with insurance. There is a copay. Even then, there is a world about the copay. How much should be the copay? How much are you charging? Even there, it depends. I give you an example of lawyers. With the same lawsuit, you can visit ten lawyers asking for the same service, but you can go from someone that is pretty much zero or very cheap to someone huge and super expensive.

They both have degrees. They both are lawyers. They both can practice, but you have a choice because you have a clear expectation. It’s the same thing when you go to a doctor or any specialist. There is any kind of price. I think that the price of a specific practice should be made by the doctor. He knows what he's offering and he is able to explain it.

With that said, let me give you an answer based on what I think, making the conversation general. How much you can charge? You have the best interest. You know what are you doing and the service you are providing. You can define a price, so you should be free to charge whatever you want as a doctor. I think on average, a pre-test is optimal. An eye test in the range of $100 is a fair price.

Your example of a lawyer is an interesting analogy. It is relevant because many of us have the perception that lawyers may be overcharging sometimes. We can appreciate that there is got to be a balance in there somewhere. Let's say I gave you the example of a lawyer, the same lawsuit as you said. One lawyer charges $50 an hour and the other charges $300 an hour. What would your perception of their work be?

On a like-for-like basis, let me say this. If you are providing safety, it should be like for like. If you get an eye test, you just go in for a pre-test, adjust refraction, and then you got the right test and you are out, you charge $50. You need to understand what are you buying. On a like-for-like basis with the same level of charge, you cannot grow 600 times, $50 and then you go to $300. That's unfair. This is not good. On a like-for-like basis, it's not acceptable. Most likely, the $300 doctor is not going to have a big following in the community on a like-for-like basis.

You need to understand what you are offering because, for $50, you are having a very basic exam. You are getting into the doctor's room for a very basic pre-test, and then you go to the refraction for a few minutes, and you get out. On the other side, if you walk through a deep pre-test examination, you go there, you walk through the visual field, you go to the outer refraction, you go to the optomap, you have an OCT, then you go to a slit lamp, and so on and so forth, you are having a comprehensive eye exam. I don’t know if you can reach the $300, but you can for sure double or $100 or $150 compared to the other one.

I used the lawyer example because I wanted to make it dramatically different. You are right. In an eye exam case, it wouldn't be six times the difference. More so the question was because you assume from the outside before you've met them or before you've gone through the due diligence that they provide a similar service. Would you perceive the higher-cost one to be potentially providing a more diligent and comprehensive service versus the one that's the lower fee?

It's back to the awareness. If you ask a potential patient what is an OCT, what is an optomap, what is a slit lamp, or what are the benefits of this stuff, we are not doing a good job. We are creating a good condition for the $50 and not giving anything. It’s commoditization. I totally agree with you. The patient is confused and the price becomes a key element to define where you go, but it's because of the industry commoditization. That's the main issue.

We need to spend time with the patient and the community. Let them understand what are you buying because otherwise, you are like the guy that is going around in Ferrari and the guy with the bicycle coming next to him and saying, "How much did you pay for this stuff to go around?" He said, "$200,000." He said, "How much do you pay for your stuff to go around?" "$200." The guy felt frustrated. He says, "How is it possible?" He didn't realize that this Ferrari is completely different stuff. You know what I mean. We need to work more.

We need to create more awareness about what a comprehensive eye exam is. What are the services that you should expect? What the different tests that you have can give to you?" When you go there, you don't see many steps of this journey. You don't see much information that you should collect. It's $50, but mainly when it comes to yourself and to the people you love, the $50, $100 or $150 is not a life change. If you can feel confident that your son or daughter is perfect, they don't have any issues. Awareness is very important. We need to make sure that we let the industry step far out from commodization.

We need to ensure that we let the industry step out from commoditization.

One of the things that you touched on right at the very beginning of the conversation that I was hoping to bring back to you now was technology. You mentioned telehealth. I would like to get your thoughts on what technology should we see coming forward, and how is it going to impact the way we perform an eye exam. How is it going to impact the optometrist's job and position as the eyecare provider?

In my point of view is the following. The current condition is creating a very favorable field for growth over tele-optometry. Back to what we said before. We have 1,700 doctors on the market. We have 1,016 that are leaving the industry because they are retired. There is a work-life balance. There are more doors and rooms coming into the market. The physical connection between a doctor and a room is going to be an issue. More rooms and fewer doctors. How can this happen? Technology is creating a highway, and I'm in favor of certain conditions that I'm going to share with you.

It is creating a highway to break this link between the physical doctor and the physical room. Putting a doctor remote that can cover more room. You are increasing access to the care. You are making this care more available to more communities. You are supporting the demand. The point is that we need to be very careful not to create a jungle because, in the world of tele-optometry, you can find lots of things.

This can be a tele-optometry between me. It's a video conference tele-optometry. In EssilorLuxottica and LensCrafters, we have the first chain in the group that we are testing this suite. We haven't created. We have built an end-to-end suite with all the equipment integrated into the same environment under a very restricted protocol that is very aligned with the comprehensive eye exams because this is what we strive for. Comprehensive eye exams, so in that case, the doctor is remote, but he has all the information to take and prescribe glasses or any medical decision.

How far is AI from taking over that? If via remote or virtual apparatus were able to collect all the data, how many steps is it until artificial intelligence takes that optometrist seat to compile the data and give a result?

We are in a situation where the doctor is remote, the patient must be in the practice. That's where we are now. If I understand what you ask, you say how far are we from both.

How far are we from the doctor potentially not being part of the equation?

That's impossible. I had the opportunity to spend a few years now in this industry, Australia and here. The eye is so complex. Not just these, you need to make sure that you are analyzing these patients and you are executing the subject interview with the patient by asking questions to him and interacting with him, and ask the following questions based on the first question that you asked him. Many venues can be open when you are doing the exam.

Only human beings have the experience that can reach this quality. We are all different from one another. Even if you are very close to another one, everything is different in terms of age or lifestyle. I strongly believe that an algorithm can never substitute a doctor. I don't think that in twenty years, we can have artificial intelligence that can substitute a doctor.

The other thing that we touched on earlier was the demand. We touched on that fair bit about the demand and the lack of supply of optometrists. Part of the impetus for this whole series of conversations was that there is a demand for optometrists. There's a mad scramble right now to recruit optometrists or new graduate optometrists. Part of that is some incentive programs that have been rolling out with certain organizations, whether it's signing bonuses or large salaries to work in certain locations or forgivable loans from some organizations.

It all looks very lucrative and glamorous for that new optometrist, but my question to you is based on all of that, do you think that that new optometrist is the person who would leverage looking at all of these incentives in front of them and making a decision based on those incentives? Is that new grad the person with the leverage or is it that these corporations are potentially clouding this optometrist decision and their career path and there could be long-term implications to those decisions?

I think that the market is in distress. There is a strong demand for doctors. Everyone wants a doctor. This is a general market rule. The more the demand is strong, the more the price goes high. We cannot do anything. It is what it is. It's an input for us. What we need to look for is a fair market value. When there is a fair market value, then there’s a fair market value to operate and that's what we have to do. Then there's the chain. The $50 cannot be anymore the $50. The $50 becomes $60, $70 or $80.

At the end of the day, it is a spiral that closes on itself. The more everything goes up, the more the service is going to go up, the more the people have to pay, and that's it. It is what it is. These are money. This is the market. This is a condition that it’s creating there, but how much this one can influence the decision of new grads? I don't see the risk because it’s the same stuff when the profession was much cheaper. You graduated yourself. I make it up. You can get $100. There is someone that can give you $120. You were moving from $100 to $120. Now, the situation is much worse. You start from $200, doubling. I make it up. You are moving from $200 to $250, but it's the same. The mindset of the doctor is exactly the same.

Money is money. These people are out of school. They have to repay the loan. They need to take the best decision in their interest from a financial standpoint. They need to repay the loan. They need to start building their lives. They need to grow and be successful in their life. I don't think that this can influence more or less the way our doctors used to make a decision and now they are making decisions. I make it up. If a doctor would like to be independent, and they were striving for this, he's going in that direction. No matter if before you could have $100 several years ago, and now you are getting $200. That's what you want to do. You go there.

I don't think that this is something different from what it used to be. If you are independent, you know that if you need a doctor operating in your practice, you pay more. You need to ask for more money. I don't think that this one can influence the way how would the doctor will operate. It's a market condition. It is what it is. There is no market that is only $100. An operator in the market is offering $500, so then yes. This can influence the potential decision of a doctor, but if everyone is on $500, you move from $490 to $510. It is what it is.

TTTP 85 Alfonso | LensCrafters

LensCrafters: If you need a doctor operating in your practice, you pay more.

Let's go a little earlier on in the educational timeline. If we rewind a little further to a student who is like how you were talking about earlier, potentially thinking about going into optometry or evaluating their options in the healthcare field. What advice would you give to that person regarding optometry?

Do it. At this moment, this is one of the best choices that a young student can do, 100%. There is no other industry so healthy as the optical industry. It's good for them. It's good for us. It's good for the patient. There is a strong demand there.

The last question I want to ask you is any other words of wisdom or any other thoughts or insights that you have regarding the profession or regarding optometry from your time in the industry that you would like to share with the audience.

The doctors in the optical industry are the main player. Most of the time, they don't come together. Listening to the view and the voice of the doctor sometimes is not easy. Instead, there are some communities, in a certain way, that should strive to make it easier to understand the need, and then all the operators can act in the direction to support them. They are amazing. They are the main player.

Without the doctor, the industry is not there. Everything starts with an exam. Everything starts from a prescription. That's what it is. It's the number one player in the industry. I personally have experienced being someone that wants to listen to the doctor play in my favor. Sometimes it is not easy. There are lots of different interests and you cannot go bold on a few things. You should do probably lots of more soft things in order to make sure that you can make everyone or as many as possible happy. I'm very happy about this kind of initiative. I can listen. I can learn which are the main concern. Personally, in my little space in the industry, I can take it into consideration, but then also the other can take into consideration all these needs. If we are all aligned, we are all moving in the direction that the doctor is looking for.

There are many different interests, and you cannot go bold on a few things. You should probably do a lot of soft things to make sure that you can make everyone happy as much as possible.

I appreciate that. That is one of the messages I'm hoping to share throughout this series of conversations. It’s that the doctors have the power and ability to make certain decisions. They have the ability to direct the profession the way we would like it to go and grow and thrive in the future. It's up to us to take that control of that. Take the reins and make those decisions and not leave it up to other players who may not have optometry's best interests at heart. I appreciate you sharing that, Alfonso. Thank you very much and thanks again for joining me on the show for The Future of Optometry series. I hope you get a chance to listen to the other conversations. They are going to be valuable if you get a chance to tune into those as well.

Please share with me everything. I can understand how far I am from the others.

That will be a good learning experience for everybody to tune into each other's conversations. I agree.

I thank you for that. Thank you for hosting me. I appreciate it.

My pleasure. Thank you, everybody. This is the fifth episode out of the six episodes in The Future of Canadian Optometry series here on the show. I will see you in the sixth and final episode.

That was the fifth of the six interviews that I conducted for The Future of Optometry series, presented by Aequus Pharmaceuticals here on the show with Mr. Alfonso Cerullo, President of LensCrafters. As he mentioned, that means he oversees Canada, the USA and Puerto Rico, a very large demographic, a very large geographical area, and a very large brand.

I hope you were able to take away some useful insights from what Alfonso had to share. Whether you feel it's positive or negative, it's all very important that we take this information and we use it for the betterment of our profession working towards growing our profession in the long term. Don't forget, there's one more episode. This was the fifth. The last and sixth episode is coming up with Dr. Kerry Salsberg. I wanted to round up this whole series of interviews with a conversation with a successful and independent optometrist, and Kerry fits the bill. He will share some very candid insights into what we need to do as optometrists to make sure that our profession succeeds.

If you haven't heard some of the previous interviews, please go back and check them out. They are going to live on the internet forever. Whether you are on Apple, Spotify, YouTube, or wherever platform, go back and check them out, and please give me your feedback. I would love to hear your thoughts.

There's a chance that I will have some of these guests back on again in the future. If there's something you think I missed, I want to go back and ask them again down the road. As always, don't forget to share this with your friends. Send a text message, put it on LinkedIn, put up a screenshot on Instagram, and I will see you guys in the next episode.

Important Links

/*START - PODETIZE*/ /*END - PODETIZE*/

Episode 84 - Essilor Canada President, Rick Gadd - The Future Of Canadian Optometry

In the fourth installment of The Future of Canadian Optometry series, Dr. Harbir Sian speaks with Mr. Rick Gadd, President of Essilor Canada. They talk about the fair amount and types of disruptions in the industry and the positive aspects they brought on. 

 

Going deeper, in this episode, Mr. Gadd discusses:

·         What he believes makes Canada a desirable market for private equity and foreign companies

·         What parallels he sees in Canada compared to the US market

·         The Essilor (the largest player in the industry) is doing to support optometry

·         How Essilor dealt with the conflict after acquiring Contacts

·         What is his organization doing to support optometry

 

Aequus Pharmaceuticals presents the Future of Canadian Optometry series. Stay tuned for all six interviews with guests from different large organizations within Canadian eye care.

Listen to the podcast here

Essilor Canada President, Rick Gadd - The Future Of Canadian Optometry

If you have been following along with this conversation about the future of Canadian optometry, then you know that these are conversations that I’m having and interviews that I’m conducting with leaders from various organizations within optometry in Canada and some of the larger organizations, FYidoctors, Eyeris, LensCrafters, and Specsavers, being one of the hot topics these days here in Canada.

The goal is to ask these leaders the questions that we would like to ask as optometrists, "What is your organization doing to support the profession? What is your organization seeing as the future of optometry in Canada? What do you as an individual see as the future of optometry in Canada?" Thankfully most of the guests have been very candid, including this episode's guest in the fourth installment of The Future of Optometry in Canada, Mr. Rick Gadd, President of Essilor Canada.

Rick being candid and open, does share a lot of insights from his perspective as the head of this gigantic organization. He has overseen so many changes within the industry, including one of the biggest pain points for us in Canada, especially in BC, the acquisition of Clearly contacts many years ago. He was very gracious in facing these questions head-on and giving the best answers that he could.

Again, looking at this from now a different perspective than some of the other interviews. For example, businesses like FYidoctors, Eyeris, and LensCrafters have storefronts and conduct business-to-consumer transactions. Rick is talking about the business-to-business transactions that he is in charge of on a day-to-day basis. He's bringing insights from his extensive experience working in the US and seeing consolidation, private equity, and foreign organizations entering the market.

What he sees in Canada as potentially similar experiences or parallels that are going on. Don't forget to share that we are having this conversation about The Future of Canadian Optometry with all of our colleagues across the country, take a screenshot, if you are on Instagram, throw it up on your Story. If you are on LinkedIn, put a link up there.

If you are not on social media, send a text message to a friend with a link to the episode or to YouTube, where you can watch these interviews in full but make sure we are spreading the word and helping our colleagues to be enlightened about this conversation and the important changes that are happening and coming for our profession in the future. Again, this episode is the fourth installment of The Future of Canadian Optometry series presented by Aequus Pharma with Mr. Rick Gadd, President of Essilor Canada. I hope you love it.

Mr. Rick Gadd, thank you so much for taking the time to join me here on the show for this very important series of discussions on The Future of Canadian Optometry. Thanks so much for being here.

Harbir, thank you so much for having me. It's a pleasure.

A couple of months back, I put a call out on show or an invitation to various organizations that have a small or large footprint here in Canada in the optometry industry and the profession. Thankfully, people like yourself have stepped forward to answer that call and come forward and share their perspectives on where our profession's heading and what's happening now.

Since I put that invitation out there a couple of months back, I have been speaking to a lot of my colleagues across the country, Coast to Coast, in all sorts of different modalities to try to understand what are their concerns and thoughts about where we are now, and taking that national temperature of the profession. I don't like using the word average but I mean our mainstream middle-of-the-bell curve optometrists and colleagues, people who are doing their day-to-day work in their clinics.

The perspective that you bring and many of the other guests that I've brought on for this conversation is a very different perspective. You are the leader or the head of one of the large, if not, maybe the largest or one of the Goliaths in the industry here as President of EssilorLuxottica Canada. I would love for you to share as much as you can candidly from that higher or a different perspective than most of us optometrists would have. The first question that I ask all the guests is this, from your perspective, how would you describe the current state of optometry in Canada?

I'm still learning about the Canadian industry, to be fair. I joined officially leading the EssilorLuxottica Canada organization at the end of March 2022. I've had the opportunity timely as there were so many meetings going on. Everybody was getting back together to meet and talk to a lot of key opinion leaders in the industry, customers that were serving, and the associations.

I would put it into a few buckets. First is that the health of the industry is quite strong in terms of demand. We have a strong need that continues to be extremely relevant in Canada and across the country. Secondly, I feel it's an under-penetrated market relative to some of the under-markets in the world. That, to me, states opportunity.

Penetration isn't just necessarily a number of people who are wearing contacts or eyeglasses but the breadth of being able to utilize visual enhancement for different needs, whether it's looking at a computer screen, being outdoors or for protective purposes, and so forth. I feel like there is an opportunity in terms of penetration.

The third dimension, though, which I knew of but it's become quite clear to me, is that it's a very attractive marketplace. In the sense that you, the Canadian market has attracted a lot of players. Probably the number of relatively large players who have entered the Canadian market is quite stunning relative to others. I will reference the US because it's an easy reference that there are some similarities in the market. The last players have entered Canada from international destinations.

To me, that says a couple of things. One is that the barriers to entry may be lessened a little bit for the Canadian market but secondly, the socioeconomic landscape and the opportunity to market are very attractive. I always remind all of my peers that Canada is the tenth largest GDP in the world. The only thing that goes against that, perhaps, is that we happen to live next door to the largest GDP in the world. Sometimes that gets muted a little bit.

TTTP 84 Rick | Essilor Canada President

Essilor Canada President: Optometry has lagged in other industries in terms of the utilization of technology to streamline business and business models to attract, engage, and retain patients and consumers.

The fundamentals of the industry are powerful. What I see is that it's a very dynamic marketplace as a result of there being so many entrants into the market. That creates a new sense of competitiveness in the marketplace. It also creates, potentially, both opportunities and risks for others that we will all have to change our approach to not just survive but thrive in this very dynamic market.

You touched on it a little bit. I’m curious because I've heard this now a lot as I have been having these conversations like in Canada. For some reason, the Canadian optical market or eye care market is very attractive, whether it’s private equity or foreign organizations. What is it about Canada in particular that you feel like somebody else would want?

To point out the elephant in the room here, a lot of these discussions that are happening now are Specsavers coming to Canada and making a big splash. For better or for worse, that's the way it is. I'm asking a question Specsavers as well, “Why is it that you have been eyeing Canada for so many years?” Rick, from your perspective and the few months, that you have been back in Canada, what is it that you think is creating that desirability?

It comes back to the structural things and some of the fundamental characteristics of the market itself. Canada is very stable politically. It's a wealthy country. Uniquely healthcare in Canada is very unique compared perhaps to other marketplaces. The awareness is there in terms of healthcare. I view vision care as part of healthcare in many dimensions. That's an area that creates attractiveness but there's something that's fundamental that there has been a premium-ness in the market. We see it in our own numbers.

When we measure, Canadians, by in large, tend to shop a little more premium. I'm going to get specific about spectacles and apparel brands, and so forth. Canada is very premium in terms of its desire to look and feel good in what they are wearing. That in itself is attractive to many entrants into the market. The last thing is that when all of us benchmark the penetration in the market, we see that there is opportunity in terms of not just share grab but in fact, growing the entire marketplace. We see the regularity in terms of eyewear purchases relative to some other markets. I feel like that that creates opportunities. There are a number of different dimensions there. Hopefully, I'm getting to the core of your question.

There's no specific direction or answer that I'm looking for. You have that unique perspective from your position, and I would like to hear from that. When I ask that question to other guests, they will give me their perspectives. You mentioned penetration a couple of times. Do you feel like there's a large portion of the population that's underserved?

When I look statistically, there are gaps in terms of access. Canada has incredible density disproportion around urban areas but there are a lot of rural areas that are not appropriately addressed. That has something to do with the penetration, the regularity of comprehensive eye exams, and so many different dimensions. We can tie that back to healthcare and access as an opportunity in the Canadian marketplace.

Even in the urban centers, there aren't as many triggers in terms of that annual comprehensive eye exam that may exist in some other markets. That leads to penetration and regularity of purchase also. Finally, there are still multi-pair opportunities I'm speaking about from the perspective of a spectacle lens company at its root. We see that in terms of performance and situational as well as fashion opportunities. People don't have as many pairs of glasses in Canada as they do in perhaps some other markets.

With various forces coming in, whether it's internally or from other countries, there has been a fair amount of disruption, generally speaking. I'm curious. In your mind, how would you describe disruption in our industry or what forms of disruption you've seen?

There is the obvious one, private equity entering the market, and through consolidation, that creates one level of disruption. When I speak about that, we can go back to when this was purely in the independent marketplace in the '90s when it was largely speaking. There were no chains to speak of. I will start with the point fundamentals of our industry as a whole. Whether you are in Canada or the US, many other markets are very attractive. Private equity identifies markets where they think that they can create efficiencies for the benefit of their shareholders or themselves. I'm probably stating the obvious but it's a very fragmented industry historically that's created some opportunities that have been ideal for that.

The industry's fundamentals are creating a new sense of competitiveness in the marketplace.

What it means practically as far as disruption is concerned is that there are always two sides to every coin. On the one hand, it elevates awareness. We see more communication and advertising. It's more organized in terms of communicating more from a commercial sense is 0.1. That can elevate awareness. That can be a positive as far as the disruption is concerned.

There is the other side of the coin for an independent optometrist with their own private practice. The level of competition or their ability to compete becomes a more challenging environment in some cases. That in itself is one level of disruption we are going through that we continue to experience. The second level of disruption is technology.

I feel like optometry has lagged, perhaps in other industries, in terms of the utilization of technology to streamline business and business models to attract, engage, and retain patients and consumers. That level of disruption is accelerating as well too. We could talk about Teleoptometry and what role it will play going forward as an example.

Certainly eCommerce, in terms of the engagement in our industry, but now, very much a percentage, and I don't know the exact percentage that eCommerce represents as far as purchases are concerned in Canada but in the US, it's roughly around 10% now of eyewear purchases. That's another level of technology disruption but it's also following the path of what consumers are seeking in terms of choice.

I will speak from a company that is largely anchored on innovation, the other level of disruption is that we've gone from correction to protection, and then prevention, now to therapeutic lenses. The scope of the practice has also gone in terms of disruption to more medically oriented and integrated. What I'm speaking about very specifically are myopia and myopia management through therapeutic lenses, whether it's contact lenses, drops or spectacle lenses. Those are areas of disruption, and disruption doesn't necessarily always mean a negative thing. It means how do we adjust to either capitalize on the opportunity or in terms of minimizing the risk?

The word disruption tends to have a negative connotation, generally speaking. An obvious question for you, though, does it have to be negative or positive forms of disruption? How do we see it? How do we make it so the disruption can be positive?

It can be an extremely positive one, competitive, in general, always challenges all of us to up our game. We need to continue to innovate, whether it's how we are attracting and retaining our patients, the patient journey in practice or we need to change our scope of practice through innovation. I'm going to deviate because it helps me a little bit to rationalize what we are going through from a reference point. When I was growing up, my dad was a veterinarian in Toronto who's now well-retired. He was in private practice his entire life.

Innovation back then was when Big Box like Petco and PetSmart, came on the scene, which was hugely disruptive for them. They had to reinvent their practice because what was a key source of seeing patients attracting patients was an annual vaccination of the dog or cat. They had to find new ways of bringing new services into the practice to continue to retain and attract new patients and patients that had high value.

My dad, at 58 years old, went back to dentistry school because dentistry was something that they felt in the practice could be valuable. There was a disruption. They decided to change the scope of practice. They educated themselves and went back out, which was very positive and additive to the practice. It's super relevant in terms of disruption. By the way, dental has become a very significant part of their practice. The margins were way better on dental than they were on doing vaccinations. Pet owners oriented themselves to where they needed to go for the service that they wanted. That's an example of a disruption that can end up in a positive outcome.

Often the concern is when there's disruption, it's the sky-is-falling mentality that this is going to be the end of the profession but often we end up, as you said, pivoting, evolving or however you want to phrase it and hopefully coming out better if we are doing the right thing. You have this perspective from the US, you can make some comparisons with our industry in particular.

TTTP 84 Rick | Essilor Canada PresidentTTTP 84 Rick | Essilor Canada President

Essilor Canada President: My job is to create not just a product and service platform around eyeglasses but also find ways that we can help our customers compete in the marketplace.

Private equity, as you mentioned, is a big force now in Canada but it's not new in the US. You've seen various large organizations formed through private equity. Overall, in your opinion, as much as you are comfortable sharing, has it been beneficial for the industry? Has it been negative? Has everything come to some equilibrium after a few years?

What has been positive is that it has challenged all participants in the industry to evaluate our business models and find ways of creating new value. We serve the entire market as EssilorLuxottica, which evaluates how we can create value for each one of our stakeholders that's going to be meaningful for them. It's hard for me to speak in terms of our competitors and so forth but from our perspective, what we see is that every single year the industry continues to grow, and that's a positive outcome.

Secondly, with these well-organized businesses that are private equity backed and there are many different players, everyone from small boutique private equity players to large ones like Goldman Sachs, as you well know, MyEyeDr is a great example. If Goldman Sachs finds our industry interesting, that says something or KKRs and others. There are some very substantial private equity institutions that find it interesting.

In the net effect, there have been those practices and doctors who have found that the timing was good for them to exit their practice and play a different role. It created an opportunity for them, and that's stating the obvious. There are also some other doctors who have found that they are more focused on the clinical aspect of their practice, and it's where they want to focus versus the soup to nuts truly independent practice where they are managing all aspects of the practice. That has certainly been an opportunity that has also been addressed and has made it attractive to some.

Bottom line is that it creates choice overall. I don't mean to be ambiguous in terms of saying, "This is good or bad," Overall, it's good. It's a natural evolution of business. We've seen it in other industries, look at dental and dermatology, you can go down the list of other professional services and solutions that private equity has been active in. What I see is that a greater awareness by patients and consumers, in general, is a very positive outcome.

Where has it been a negative? "I want to stay independent. I want to own my practice." In the end, is that they need to seek help partners to help them succeed in a much more competitive environment. That's a reality. "How do I distinguish myself when I've got this marketing, prowess, and presence in the market? How do I elevate my voice as an independent optometrist?" These are all things that have a negative potential outcome for an independent but at the same time, there are means and ways to reinforce them. It not only just survive but thrives through specialization and differentiation.

I should clarify for people who are reading in case I haven't already. In EssilorLuxottica, your position is not consumer-facing. The other guests I’ve had are the head of FYidoctors or whatever. They have their banner stores that readers are probably thinking of, and your position is a bit unique in the series of conversations because your entity that you are at the top of is dealing with the businesses themselves on that side or EssilorLuxottica.

You have a very different and broader perspective because you are working with private practices, the private equity type of organizations, and these other large players to clarify for everyone who has been reading this. Rick's position here is not the head of LensCrafters stores. It's the other side of the business.

Thank you for the clarification.

We've talked about this before, and you are keenly aware of our feelings here, especially in BC of Clearly contacts. Several years ago, there was this big disruption and big deregulation here. Clearly essentially, they infiltrated the government and had things change to their benefit, which ultimately, from my perspective, was to the detriment of the profession. Some years later, Essilor had acquired Clearly for a large sum of money. First, I want to ask you, from your understanding and experience. What was the Canadian sentiment towards Essilor at that time, and then a few years later, do you feel that's shifted, and what is it now?

The fundamentals of the optometry industry are attractive, and private equity identifies markets that can create efficiencies.

I will give you my perspective. I wasn't involved in the transaction but I was with Essilor of America at that time when the acquisition was done. A lot of people might say, "Why did you do it?" It was not EssilorLuxottica, and it was not Essilor that did the acquisition. They had no eCommerce strategy but as a whole, we saw eCommerce starting to elevate. It was an opportunity that was presented. That's the background behind it.

Honestly, as a company, we felt that we could be good stewards. We thought about, "Where else?" because it was clearer that Clearly was going to be sold. We felt that we could be good stewards of that acquisition. One can argue whether or not we have been but nonetheless, our intention was to acquire this to start to learn a very basic sense of eCommerce and determine what our role should be going forward. That's the background.

My perception is that Essilor was viewed quite commonly as a partner to the Independent Eye Care Professionals. I'm going to assume that because I wasn't in the Canadian market at that time but I knew what our reputation in the US has been and continues to be as a partner for Independent Eye Care Professionals. I don't know that there was a reaction to the acquisition and that it was not necessarily a positive one.

There were some mistakes made along the way. One is that we should have clarified what were our intentions. There were commitments that were made around how we would behave in the marketplace, and certainly, that was our intention to do so. As I look forward, here's what I see, eCommerce is a reality. Our customers understand that it is part of the business model in the marketplace. Do they think that we should be participating? You will get as many answers as you will have from individuals who are in the industry. Some continue to find that unacceptable.

My response is that we have several lines of business. We are competing with our customers in eCommerce and own LensCrafters, that's another example. What we have tried to do is provide choice at the end of the day. My job is to create not just a product and service platform around eyeglasses but, in fact, to find ways that we can help our customers compete in the marketplace. That's what our intention is to do. We want to elevate the entire industry but also recognize that consumers will exercise choice as a vertically integrated player but as a single player.

Another thing about EssilorLuxottica, we don't have any other business. We are wholly into optical. If we are not successful in this business, then frankly, we don't have a plan B. We are in optical, and that's all there is to it. I've talked to people, including yourself. You started by saying we've had this conversation, and that's a point of stress in the relationship. We communicate regularly back and tell them, "Here are the things that are concerning to our customers very specifically." We try and act as good stewards to create that connection.

I, in fact, went to the president of Clearly and said, "Here are some concerns that we need to try and work through." If I can say anything, that's an open line of communication, and we are vested. We have to balance all of our business needs. It's an important and material conversation to have that, so we have a voice.

The second thing is that it's on me, my team, and my company to create value that's incremental to being a transactional relationship that we need to elevate and help you succeed in the marketplace. The second comment is that we work very hard on doing that, not just through the products and innovation that we provide in terms of the actual material itself but in the way we support the practices through marketing platforms, driving traffic to the practice, and so forth. Do I wish that everybody would love us? I absolutely do. It's probably my nature.

It bothers me when people have concerns about me but again, in a very pragmatic way, I take the feedback and try and direct it in a positive way that moves our business forward. I ask to be judged. The final point is that I feel that's a point of judgment and fair enough, then judge all of our competitors in the same way. We all have relationships in the industry. Some of us own certain assets that may be more obvious. At the end of the day, I would ask only that your readers judge us in terms of the value that we create. It's a very personal choice, and I completely respect that.

First of all, I'm humbled that after our conversation, you felt compelled to speak. I've seen that whole scenario play out from my own biased perspective of an independent practice optometrist or an optometrist based here in BC. The timing was very unique for me. I graduated in 2010, and as I was coming out to practice, that's when all of that disruption happened. It was very plain for me to see when it happened but over time, I've realized now, as we are talking, that there's the other aspect of your customers, as you've referred to a few times are optometrists and other eyecare professionals.

TTTP 84 Rick | Essilor Canada President

Essilor Canada President: What a patient recognizes as the quality of care is the interaction with the doctor and the staff. The comprehensiveness of the engagement, the utilization of the technology, and the instrumentation lead to a positive experience.

From that perspective, the acquisition of an eCommerce player, which is technically my competition, does seem like there's a conflict there. I can see how that would be difficult for people to reconcile it. It's a business decision. At the end of the day, you are running a business. It’s fine. There seems to be a conflict there. You are serving practice practitioners like myself, and at the same time, you own what seems to be my competition. How do you reconcile that, then?

A few things, one is that I reconcile it by trying to create value every single day to earn your business and to help you succeed in the marketplace. My sole motivation is to be a good partner to you. Secondly, as far as our participation in the market and, as I stated, we are a vertically integrated player in the market. We have been for a very long time. That is part of how we create value in the marketplace. Thirdly, we cannot ignore that consumers will make choices about how they want to purchase eyewear and contact lenses.

Clearly is a very big player in the context of contact lenses in Canada. In the sense that they are a relatively small player, and I don't mean to take anything away from Clearly or their success. It's just that there are multiple entities that are participating here because consumers, ultimately, are looking for choices. We feel that we need to be there for them at several different junctures. I will leave you with one thing. There are certain things that we will not compromise. If you look at any of our entities and our consumer or patient-facing, the one thing that's so foundational to us is that a comprehensive eye exam is what we stand for.

From a clinical perspective, reusing an old prescription and things of that nature are completely out of balance. We are committed to a comprehensive eye exam, not only refraction. It's the cornerstone of healthcare and something that we feel is very powerful and differentiating in optometry. It's a critical role that optometry plays in the entire healthcare system, not only in terms of eyecare but in disease states that are identified. It's fundamental to the company. It's not just me.

There are other players who are less concerned in the industry that may have eCommerce platforms that are less concerned about the starting point of a comprehensive eye exam, which is important. As we reinforce that, it is an opportunity to engage that customer or patient in your practice, wherever they may be. In the end, it's a balance, and I fully recognize that but we work very hard to keep the fundamentals front and center.

Speaking of comprehensive eye exams, in your opinion, what factors are involved in a patient's perceived value of the eye exam service? Before they walk into a clinic or after they leave it, what do you think helps a patient decide whether they received good value for the service they had?

The patient journey, in general, is differentiated in many different practices, retail locations, etc. The quality of care is the starting point. For all of us, it's the quality of care and the sense of quality in terms of that journey from the time that they enter the practice until the time they exit the practice. There's a high degree of variability that exists now but what a patient recognizes as the quality of care is the interaction with the doctor, staff, and the comprehensiveness, in terms of the engagement and the utilization of the technology and the instrumentation that leads to a very positive experience or not a positive experience.

Coming out with a diagnosis and a plan for their vision is how value is created on behalf of the patient, and ultimately, it's the patient's choice whether or not they act upon that like any aspect of healthcare. The additive there is that linking the conclusion of the comprehensive eye exam that is very clinically focused and then translating that into, "Here are my recommendations in terms of how to enhance, protect, prevent, and correct, and then ultimately, enhance your life through this set of visual solutions for you."

What role do you think price plays on that perceived value?

I'm not so sure that I am qualified to answer a price question other than to say that if the price is too low, then the perception of value goes down. If the price is too high, then it feels like access is being challenged. What's the balance in there? I won't put a dollar figure on it for you because I don't have a dollar figure.

Multiple entities are participating because consumers are looking for choices. We need to be there for them at several different junctures.

That was going to be my next question. The question I ask every guess is, how much do you think a high-quality, comprehensive eye exam should cost? I understand it's a difficult question, and it's not simply about the number. It’s about the conversation that happens after the questions are asked. How much do you think it's worth?

You put me on the spot. It's $150 or $175 for the initial exam itself, and then there's an adjunct on that as well. As you identify in the pre-screening, there may be areas that you identify that there are incremental tests required that should be incremental in terms of the cost associated with it. That's why I say it's a little bit hard for me to put an actual dollar figure on it because it can range.

If somebody is young, their health is good, you are less likely to find a disease state. It can be a more efficient eye exam. It should be a comprehensive eye exam and imaging associated with it to conclude that there are no disease states that are happening or that there isn't something problematic. At the same time, for somebody my age, my visual needs have changed over the years but also things that have been identified along the way. I've felt powerful.

My optometrist identified that I have macular degeneration, and it was horrifying to me but I'm glad he caught it so that I can manage it. What’s that worth for me? That's worth a lot to me because I can manage the state in itself at its very early stage. It's almost like I put a value on that's incremental, and had I not had that high degree of imaging, that would not have been identified. Until it was an advanced disease state, and then it's much more difficult to manage as it is. Preaching to the choir, you know way more about this than I did.

You touched briefly on Teleoptometry. That's certainly something I would like to dig into a little bit. As far as the implementation of technology in optometry, Telehealth being one, do you see other forms of technology being implemented that will change the way we perform an eye exam?

Yes. From an instrumentation perspective, imaging is an area that has so many possibilities. It's gotten so much better. In general, managing disease states and expanding the scope of practice is something that's a real opportunity for optometry. When I think about technology in general, the ability then to also be able to transmit that data in a secure environment, those images that are high quality, high-definition to get timely expert opinions or real-time as opposed to having to wait for an expert entity to be able to evaluate an image. Those are very positive progressions in terms of our industry and the possibilities to be able to address issues in a much shorter timeframe with a great deal of efficiency and also access.

That's the other area for me that's important. It's not accessible in the sense of being able to get an eye exam but access to a small pool of experts that can then be able to aid the local practice in terms of evaluation, recommendation, and the next steps. It's creating a pool and a panel of doctors that are more connected. In a very connected world, that seemed to me to be a super powerful opportunity. That in itself is interesting.

The second part of that is accessed, though. We start out talking about rural communities and the ability to access optometrists and where in some communities where they don't exist. The reach by utilizing technology, Teleoptometry being the discussion point, is super powerful. It can be enhancing for the doctor and patient. It opens up new doors in terms of regularity and interaction but it cannot be compromised.

It falls back on a comprehensive eye exam. I'm using my iPhone as I talk to you but I do not see a foreseeable future where that can replace a comprehensive eye exam. That is simply ludicrous. There needs to be that interaction or evaluation and recommendation in terms of expertise that cannot be replaced.

It's a very rich topic and one that I find exciting. It's being evaluated by different associations, and different recommendations across the country in Canada, the AOA in the US is also taking a position, and the CAO is also collaborating in the North America perspective in sharing data and taking a position. I had a comprehensive eye exam completed in a pilot that was being run in the US. I'm a high-touch person, so I like to see a doctor or an optician. I did not feel that I walked away from that having a bad experience. In fact, it was a good experience but as you and I are talking, the doctor was there. They were live.

TTTP 84 Rick | Essilor Canada President

Essilor Canada President: Technologies are very positive progressions in our industry and offer possibilities to address issues in a much shorter timeframe with a great deal of efficiency and also access.

The most important part of the connectivity through all of this was the ability that the doctor was in control of in this scenario. They were doing the refraction, looking at my retinal images, pointing them out, and walking me through, "This is what we saw. This is our recommendation." It holds a lot of promise but again, it was a live doctor, and that was the power. If it were something where that interaction didn't occur, then I would've seen that it was low value, and perhaps I would not have trusted it as much.

There are a lot of potentials, and we are in an industry that's growing. Although there's a lot of competition and need for optometrists. How do you efficiently have the optometrist in places where they are needed? There are a lot of things that can be done here to enhance the practice and enhance it for the doctors as well as the patients.

In that scenario where you had that exam, foreseeably, when it is implemented somewhere, is it a technician that's conducting the tests, and there's a doctor who's watching?

It was a pre-screen where a technician did the pre-screen, the way that you would have one of your staff members doing a pre-screen. I then went into the exam room. There was a technician in the room. The doctor was on the screen, and I was looking at the doctor in front of me but the doctor was remotely controlling the equipment. It wasn't the technician that was operating the equipment. They weren't saying to the technician to make adjustments. They were able to control it. That's what I found very reassuring.

Was the retinal evaluation primarily done with the photograph or digital imaging? Was there any form of lifetime active viewing?

There was lifetime active viewing.

As you stated already, our industry tends to be quite slow to move on to technology, generally speaking, Even if you won't agree with that. I will say that very bluntly when I do lectures on eCommerce and stuff like that, and we are slow to move on a lot of stuff. When technology like this comes around, where it potentially can improve and allow greater access to care, it still seems a little scary. There will still be some form amount of pushback, as I imagine you would expect.

For a couple of reasons, one is the potential loss of the accuracy or technical ability to diagnose. I know you will say technology is very good and it catches everything fantastic but the second one is the bigger one, as artificial intelligence plays a big role already in healthcare. There's a concern that "You got all the technology. You implement the little AI, then where does the optometrist come in on this?" Do you think that's something that we have to worry about?

It's something that healthcare needs to be cautious of. I use healthcare as opposed to eyecare because, at every intersection, there is always a risk of somebody who says, "AI can take care of everything." The training has certainly continued to be enhanced through the optometry schools. There's always a risk but that's the important role that the industry holds as a whole. The associations need to stand up for the right things when they are interfacing with governmental institutions so that the government understands exactly what they are speaking about and what the recommendation is and what are the risks associated with it.

That's where each one of the provincial associations of optometry or the Canadian Association of Optometry, that's the thing that they need to speak loudly and well-educated on. It can't be perceived as a fear of loss of revenue. It is about the sanctity and the importance of the comprehensive and the quality of the eye exam to make sure that it’s not compromised. As long as we are clear in what our commitments are and what could potentially be at risk. It has got to be fact-based as well, too. AI has a role to play, to be super clear but AI isn't replacing the optometrist. It enhances what the optometrist can do on behalf of the patient for the patient.

Optometry is very largely sustainable in terms of demand. We need more optometrists so long as we don't dilute the caliber of optometrists graduating.

As you may know, there are various incentives being thrown around, whether it's high salaries, signing bonuses or forgivable loans, to help attract these young doctors. Initially, I thought that was fantastic. I'm putting this out there as my thoughts, and I would love for you to share what you think of it. It's not exactly phrased as a question.

My thought was, "Is the young optometrist the person with the leverage and the power in this situation or do organizations know that the money will help draw them in a certain direction, and it may end up clouding their decision?" This may affect the trajectory of their career if they end up in a position where a few years from now, they are not so happy, not fulfilled or not doing something that's helping to help the profession grow. I had that conflicting thought in my own mind.

We see this not just in optometry but we know that their employment is not what it was. There's high demand and signing bonuses going on in multiple industries with different people with different backgrounds and so forth. It's not exclusive to optometry but it certainly amplified what we are seeing in terms of demand. What does that mean? I don't think it's a forever thing, to be quite honest with you. It's a now thing.

The sustainability behind those models gets pretty tough. We are not participating. I'm giving you a personal opinion. The long-term sustainability of that means that your cost structure goes up. How do you offset that? For the moment, there's a burst capacity need that's required by many others. How will that impact the graduates? I suppose it could influence them to maybe not sample the many options available to them. It may target them to stay within a certain model.

One of the things that I found interesting with some optometrists is that they've had different experiences throughout their life. They have been an independent private practice or associated with LensCrafters but still remained independent. They've worked in corporate. A guy that you and I both know, Dr. Howard Purcell at NECO, has done a lot of different things in optometry. He's the President of NECO. He was in private practice and an academic. Does that polarize someone to say, "I got to stay on this trajectory?" I don't know. Maybe it's possible.

I truly don't think this is a forever thing. It's like employment is in the world, in general, or certainly in North America. There's high demand for employment for certain capabilities. That is a competitive situation. Let me go back and see what I said. Optometry is very largely sustainable in terms of demand. We need to have more optometrists as long as we don't dilute the caliber of optometrists graduating because eyecare and healthcare still have so much potential. There will continue to be a strong demand there. We need to solve the demand side of the equation as far as people are concerned.

The last but very important question. The core of this whole series of discussions, when I put that initial invitation or call out is that you are throwing money out there to optometrists or doing certain things to help individual optometrists gain employment and to be financially secure. Ultimately, the question is, what is your organization doing to help support the growth and the strength of the profession of optometry in the long-term?

Thank you for the opportunity to state that. I feel very strongly about this. We are a company that is built on innovation. I joined Essilor in 2011, and one of the things that struck me was the depth of innovation that it created, and it was the same thing I felt about Luxottica in terms of innovation. Why is innovation important? It will perpetuate the industry. I didn't come from an optical background, so it was hard for me to imagine that eyeglasses that had been around for hundreds of years could have innovation associated with them.

Experiencing the continuous progression in terms of the technology, the designs, AR codings, and the fashion component of what we do. We have inspirational brands that make people feel good. They want to be associated with something that's very unique and special to them, whether it's Oakley or Ray-Ban. We have 30 different brands that we represent. Up and down the value scales as well too, from Prada, Vogue, Costa, and I could go on and on.

What we try and do is, first of all, create that consumer desire for great brands. When they enter into the practice, we want to make sure that they have a choice. We are known for Varilux, Crizal, and Transitions as key brands, and we are very proud of them but we serve the entire market at every price point in terms of lens technology. We constantly press on innovation. Our investments in myopia or presbyopia are continuing to find ways of developing therapeutic solutions, and that's all built on innovation.

TTTP 84 Rick | Essilor Canada President

Essilor Canada President: The sanctity and importance of the comprehensive eye exam and the quality of the eye exam are what the Canadian Association of Optometry should be speaking about loudly to ensure it's not compromised.

I was always proud to say that we spend between 3% and 4% of our top line as a company back on innovation every single year from an R&D perspective. That's huge. That's more than all of our competitors combined. We are committed deeply to innovation but it's not innovation based on product. That's what we are known for but it's innovation. I talked about having innovative solutions for practices to help them succeed in the marketplace, whether it's an integrated supply chain. This stars program that looks Luxottica or an EL 360 program that we've developed to help not only in terms of driving a good outcome with the patients in the dispensary but also offering incremental value to the practice to find ways that we can help them succeed again in the market.

That's where innovation is at the core of what we do. That's how we add value. Finally, we have to. That's at our roots. Our partnership with Meta on Ray-Ban's stories is the tip of the iceberg. That will be another wave of innovation that will come into the industry. We are deeply committed. How do we bring that to life? It's not like we are the first people who've integrated something into eyewear but what we've done is that Meta and ourselves have chosen each other as partners on this journey. A two very powerful brands with ecosystems. We are inviting everyone because we are an open network.

My closing comment is that while we show up in many different ways, we are an open network. Leonardo is a learning platform, which we are extremely excited about. It's open to all. We are trying to play our role, as you stated very accurately. We are one of the largest players in the industry that comes with responsibility. The responsibility for us is to give vision a louder voice, elevate the industry in ways that we can, create a demand, and constantly innovate so that we can progress the industry and create value for everyone.

That's how we try and do it and say it humbly. From the CEO's office and down, that's what drives us every day as they see more, be more, and live life to its fullest. It's generally our North Star. I am personally excited to be on the journey. I'm sure happy that in 2011, I made a decision to join the optical industry because it's an amazing industry, and I love being a part of it.

Thank you so much, Rick. Thanks so much for being here for answering the questions, even some of the more challenging ones, and being open to having that discussion. I appreciate you being on this.

It's my pleasure. Again, thank you for having me, Harbir.

There it was. That was the fourth installment of The Future of Canadian Optometry series presented by Aequus Pharma. That interview was with Mr. Rick Gadd, President of Essilor Canada. As I mentioned in the intro, I'm sure you took a lot of insight away from that. Rick brings incredible insight with so much experience in the industry from the US to Canada. I felt like I took a lot of information there that I can use to have conversations with our colleagues and hopefully help guide our profession in the right direction, collaboratively altogether.

Don't forget we are having these conversation with six episodes or installments of this The Future of Canadian Optometry series. This one was the fourth. We have two more interviews to go. At the fifth installment is with Mr. Alfonso Cerullo, who is the President of LensCrafters in North America. The sixth then final installment is a great interview with Dr. Kerry Salsberg, who is an independent practitioner and optometrist, to talk about how we can, as independent and associate ODs, be successful and help to guide our profession in the right direction. Make sure you stay tuned.

Don't forget to share this on Instagram, LinkedIn, Facebook, wherever you live, and spend your time. Call a friend and let them know that this conversation's happening. As always, I'm very open to your feedback. I would love to hear what your thoughts are so we can continue to have these conversations and hopefully have bigger and better conversations over time here on the show. I will see you in the next episode.

Important Links

About Rick Gadd

Rick Gadd is President of Essilor North America and responsible for the company’s overall vision and planning, including all aspects of the business, mission and culture. A proven leader and advocate for Essilor’s mission of improving lives by improving sight, he is passionate about the customer experience and is highly regarded for delivering results.

Rick joined Essilor of America in 2011 as Senior Vice President Key Accounts. Most recently, he was President, ECP Sales and Services, and was responsible for developing and leading best-in-class teams to accelerate sales growth and customer satisfaction through ECP partnership and unique product and service innovation.

Prior to joining Essilor, Rick was Vice President of Sales for Motorola’s Mobile Devices business where he managed the wireless carrier relationship, demand generation and revenue growth for Motorola in Canada and the USA. He has more than 20 years of high-tech sales, marketing, product management and business development experience. Rick obtained his bachelor’s degree and his BBA in marketing and finance from York University in Toronto, Canada.

“I’m proud of Essilor’s commitment to our customers to provide innovative products and innovative business solutions. Innovation is our catalyst for growth.”

/*START - PODETIZE*/ /*END - PODETIZE*/